RARE vs. REMX
Compare and contrast key facts about Ultragenyx Pharmaceutical Inc. (RARE) and VanEck Vectors Rare Earth/Strategic Metals ETF (REMX).
REMX is a passively managed fund by VanEck that tracks the performance of the MVIS Global Rare Earth/Strategic Metals Index. It was launched on Oct 27, 2010.
Performance
RARE vs. REMX - Performance Comparison
Loading graphics...
RARE vs. REMX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RARE Ultragenyx Pharmaceutical Inc. | -6.87% | -45.33% | -12.02% | 3.22% | -44.90% | -39.25% | 224.12% | -1.77% | -6.25% | -34.03% |
REMX VanEck Vectors Rare Earth/Strategic Metals ETF | 19.76% | 92.95% | -35.02% | -19.18% | -31.13% | 79.81% | 64.82% | 0.74% | -49.63% | 82.60% |
Returns By Period
In the year-to-date period, RARE achieves a -6.87% return, which is significantly lower than REMX's 19.76% return. Over the past 10 years, RARE has underperformed REMX with an annualized return of -10.71%, while REMX has yielded a comparatively higher 10.31% annualized return.
RARE
- 1D
- 2.24%
- 1M
- -6.95%
- YTD
- -6.87%
- 6M
- -28.58%
- 1Y
- -36.70%
- 3Y*
- -18.86%
- 5Y*
- -28.32%
- 10Y*
- -10.71%
REMX
- 1D
- 0.60%
- 1M
- -14.22%
- YTD
- 19.76%
- 6M
- 32.63%
- 1Y
- 128.04%
- 3Y*
- 4.25%
- 5Y*
- 5.33%
- 10Y*
- 10.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RARE vs. REMX — Risk / Return Rank
RARE
REMX
RARE vs. REMX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ultragenyx Pharmaceutical Inc. (RARE) and VanEck Vectors Rare Earth/Strategic Metals ETF (REMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RARE | REMX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.51 | 2.67 | -3.19 |
Sortino ratioReturn per unit of downside risk | -0.27 | 3.10 | -3.37 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.39 | -0.44 |
Calmar ratioReturn relative to maximum drawdown | -0.74 | 5.48 | -6.22 |
Martin ratioReturn relative to average drawdown | -1.39 | 16.18 | -17.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RARE | REMX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.51 | 2.67 | -3.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.53 | 0.13 | -0.66 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.19 | 0.28 | -0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | -0.10 | 0.00 |
Correlation
The correlation between RARE and REMX is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
RARE vs. REMX - Dividend Comparison
RARE has not paid dividends to shareholders, while REMX's dividend yield for the trailing twelve months is around 1.47%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RARE Ultragenyx Pharmaceutical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
REMX VanEck Vectors Rare Earth/Strategic Metals ETF | 1.47% | 1.76% | 2.56% | 0.00% | 1.56% | 5.25% | 0.81% | 1.64% | 12.43% | 2.89% | 2.23% | 4.77% |
Drawdowns
RARE vs. REMX - Drawdown Comparison
The maximum RARE drawdown since its inception was -89.57%, roughly equal to the maximum REMX drawdown of -90.20%. Use the drawdown chart below to compare losses from any high point for RARE and REMX.
Loading graphics...
Drawdown Indicators
| RARE | REMX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.57% | -90.20% | +0.63% |
Max Drawdown (1Y)Largest decline over 1 year | -55.36% | -23.35% | -32.01% |
Max Drawdown (5Y)Largest decline over 5 years | -84.01% | -73.34% | -10.67% |
Max Drawdown (10Y)Largest decline over 10 years | -89.57% | -73.34% | -16.23% |
Current DrawdownCurrent decline from peak | -87.92% | -59.46% | -28.46% |
Average DrawdownAverage peak-to-trough decline | -54.29% | -67.01% | +12.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.35% | 7.92% | +21.43% |
Volatility
RARE vs. REMX - Volatility Comparison
Ultragenyx Pharmaceutical Inc. (RARE) has a higher volatility of 18.41% compared to VanEck Vectors Rare Earth/Strategic Metals ETF (REMX) at 15.48%. This indicates that RARE's price experiences larger fluctuations and is considered to be riskier than REMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RARE | REMX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.41% | 15.48% | +2.93% |
Volatility (6M)Calculated over the trailing 6-month period | 67.91% | 37.90% | +30.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.88% | 48.17% | +23.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.12% | 39.75% | +14.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 55.60% | 36.60% | +19.00% |